Eculizumab For the Acute Attack of Neuromyelitis Optica Spectrum Disorder
Clinical trial NCT07184840 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07184840
- Sponsor
- Tianjin Medical University General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-09
- Primary completion
- 2026-04-28
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.